Alexion Pharmaceuticals, Inc. (ALXN)
Growth
Revenue 5Y17.82%
Revenue 3Y20.43%
EPS 5Y32.42%
EPS 3Y11.63%
Dividend 5Y-
Dividend 3Y-
Capital Efficiency
ROIC16.01%
ROE5.98%
ROA3.66%
ROTA4.37%
Capital Structure
Market Cap40.34B
EV39.44B
Cash3.43B
Current Ratio4.52
Debt/Equity0.33
Net Debt/EBITDA-0.83
ALXN
Income Statement
Select a metric from the list below to chart it
Jul '96
Jul '01
Dec '07
Dec '12
Dec '17
| Income Statement | Dec '12 | Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,551.3 | 2,233.7 | 2,604.0 | 3,084.0 | 3,551.1 | 4,131.2 | 4,991.1 | 6,069.9 | 6,261.6 | ||
| Revenue % Chg. | 36.8% | 44.0% | 16.6% | 18.4% | 15.1% | 16.3% | 20.8% | 21.6% | 18.2% | ||
| Cost of Revenue | 177.6 | 173.9 | 233.1 | 258.0 | 454.2 | 374.3 | 394.5 | 553.5 | 567.2 | ||
| Cost of Revenue % Chg. | 143.8% | -2.1% | 34.1% | 10.7% | 76.0% | -17.6% | 5.4% | 40.3% | 34.9% | ||
| Gross Profit | 1,373.8 | 2,059.9 | 2,371.0 | 2,826.0 | 3,096.9 | 3,756.9 | 4,596.6 | 5,516.4 | 5,694.4 | ||
| Gross Profit % Chg. | 29.4% | 49.9% | 15.1% | 19.2% | 9.6% | 21.3% | 22.4% | 20.0% | 16.8% | ||
| Gross Profit Margin | 88.6% | 92.2% | 91.0% | 91.6% | 87.2% | 90.9% | 92.1% | 90.9% | 90.9% | ||
| Gross Profit Margin % Chg. | -5.4% | 4.1% | -1.3% | 0.6% | -4.8% | 4.3% | 1.3% | -1.3% | -1.2% | ||
| R&D Expenses | 317.1 | 513.8 | 709.5 | 757.0 | 878.4 | 730.4 | 886.0 | 1,002.9 | 1,091.1 | ||
| R&D Expenses % Chg. | 42.4% | 62.0% | 38.1% | 6.7% | 16.0% | -16.8% | 21.3% | 13.2% | 22.5% | ||
| Selling, General, & Admin Expenses | 489.7 | 630.2 | 862.6 | 954.0 | 1,094.4 | 1,111.8 | 1,261.1 | 1,399.9 | 1,422.9 | ||
| Selling, General, & Admin Expenses % Chg. | 27.3% | 28.7% | 36.9% | 10.6% | 14.7% | 1.6% | 13.4% | 11.0% | 9.5% | ||
| Other Expenses | 0.4 | - | 116.6 | 322.0 | 320.1 | 320.1 | 309.6 | 253.7 | 233.2 | ||
| Other Expenses % Chg. | - | - | - | 176.2% | -0.6% | - | -3.3% | -18.1% | -23.1% | ||
| Operating Income | 566.6 | 915.9 | 682.3 | 793.0 | 804.0 | 1,594.6 | 2,139.9 | 2,859.9 | 2,757.5 | ||
| Operating Income % Chg. | 24.9% | 61.7% | -25.5% | 16.2% | 1.4% | 98.3% | 34.2% | 33.6% | 15.8% | ||
| Operating Income Margin | 36.5% | 41.0% | 26.2% | 25.7% | 22.6% | 38.6% | 42.9% | 47.1% | 44.0% | ||
| Operating Income Margin % Chg. | -8.7% | 12.3% | -36.1% | -1.9% | -11.9% | 70.5% | 11.1% | 9.9% | -2.1% | ||
| Total Other Income/Expenses Net | -40.3 | -43.8 | -184.2 | -217.0 | -256.2 | -1,352.4 | 38.9 | -2,290.9 | -2,249.5 | ||
| Total Other Income/Expenses Net % Chg. | 27.9% | 8.6% | 320.7% | 17.8% | 18.1% | 427.9% | - | - | 2687.5% | ||
| Income Before Tax | 526.3 | 872.1 | 498.1 | 576.0 | 547.8 | 242.2 | 2,178.8 | 569.0 | 508.0 | ||
| Income Before Tax % Chg. | 32.4% | 65.7% | -42.9% | 15.6% | -4.9% | -55.8% | 799.6% | -73.9% | -77.9% | ||
| Income Before Tax Margin | 33.9% | 39.0% | 19.1% | 18.7% | 15.4% | 5.9% | 43.7% | 9.4% | 8.1% | ||
| Income Before Tax Margin % Chg. | -3.2% | 15.1% | -51.0% | -2.4% | -17.4% | -62.0% | 644.6% | -78.5% | -81.3% | ||
| Income Tax Expense | 273.4 | 215.2 | 353.8 | 177.0 | 104.5 | 164.6 | -225.5 | -34.4 | -27.0 | ||
| Income Tax Expense % Chg. | 91.5% | -21.3% | 64.4% | -50.0% | -41.0% | 57.5% | - | 84.7% | 63.2% | ||
| Net Income | 252.9 | 656.9 | 144.4 | 399.0 | 443.3 | 77.6 | 2,404.3 | 603.4 | 681.8 | ||
| Net Income % Chg. | -0.8% | 159.8% | -78.0% | 176.3% | 11.1% | -82.5% | 2998.3% | -74.9% | -71.3% | ||
| Net Income Margin | 16.3% | 29.4% | 5.5% | 12.9% | 12.5% | 1.9% | 48.2% | 9.9% | 10.9% | ||
| Net Income Margin % Chg. | -27.4% | 80.4% | -81.1% | 133.3% | -3.5% | -85.0% | 2464.5% | -79.4% | -75.7% | ||
| Weighted Avg. Shares Out | 195.5 | 198.1 | 213.4 | 224.0 | 223.9 | 222.7 | 223.2 | 219.1 | 219.7 | ||
| Weighted Avg. Shares Out % Chg. | 2.7% | 1.3% | 7.7% | 5.0% | -0.0% | -0.5% | 0.2% | -1.8% | -1.3% | ||
| EPS | 1.3 | 3.3 | 0.7 | 1.8 | 2.0 | 0.3 | 10.8 | 2.7 | 3.1 | ||
| EPS % Chg. | -3.7% | 157.4% | -79.5% | 161.8% | 11.2% | -82.4% | 2990.8% | -74.6% | -70.6% | ||
| Weighted Avg. Shares Out Dil | 199.7 | 201.6 | 215.9 | 227.0 | 225.4 | 224.5 | 224.8 | 219.1 | 220.7 | ||
| Weighted Avg. Shares Out Dil % Chg. | 0.6% | 1.0% | 7.1% | 5.1% | -0.7% | -0.4% | 0.1% | -2.5% | -1.4% | ||
| EPS Diluted | 1.3 | 3.3 | 0.7 | 1.8 | 2.0 | 0.3 | 10.7 | 2.7 | 3.1 | ||
| EPS Diluted % Chg. | -0.8% | 156.7% | -79.4% | 162.7% | 11.9% | -82.5% | 2995.6% | -74.6% | -70.9% | ||
| Interest Expense | 4.1 | 3.0 | 47.7 | 97.0 | 98.4 | 98.2 | 77.8 | 104.7 | 106.0 | ||
| Interest Expense % Chg. | -44.4% | -27.5% | 1501.1% | 103.2% | 1.4% | -0.2% | -20.8% | 34.6% | 26.6% | ||
| EBIT | 522.2 | 869.1 | 450.4 | 479.0 | 449.4 | 144.0 | 2,101.0 | 464.3 | 402.0 | ||
| EBIT % Chg. | 33.8% | 66.4% | -48.2% | 6.4% | -6.2% | -68.0% | 1359.0% | -77.9% | -81.9% | ||
| EBIT Margin | 33.7% | 38.9% | 17.3% | 15.5% | 12.7% | 3.5% | 42.1% | 7.6% | 6.4% | ||
| EBIT Margin % Chg. | -2.2% | 15.6% | -55.5% | -10.2% | -18.5% | -72.5% | 1107.7% | -81.8% | -84.7% | ||
| Depreciation & Amortization | 28.7 | 46.9 | 166.6 | 396.0 | 496.7 | 405.3 | 376.8 | 329.4 | 315.7 | ||
| Depreciation & Amortization % Chg. | 20.1% | 63.6% | 255.0% | 137.7% | 25.4% | -18.4% | -7.0% | -12.6% | -14.4% | ||
| EBITDA | 550.9 | 916.1 | 617.0 | 875.0 | 946.1 | 549.3 | 2,477.8 | 793.7 | 717.7 | ||
| EBITDA % Chg. | 33.0% | 66.3% | -32.6% | 41.8% | 8.1% | -41.9% | 351.1% | -68.0% | -72.2% | ||
| EBITDA Margin | 35.5% | 41.0% | 23.7% | 28.4% | 26.6% | 13.3% | 49.6% | 13.1% | 11.5% | ||
| EBITDA Margin % Chg. | -2.7% | 15.5% | -42.2% | 19.7% | -6.1% | -50.1% | 273.4% | -73.7% | -76.5% |